Best Hematologist Tucson Near Me

4worldlovers:
Abdelaziz, Ahmed, and Ulka Vaishampayan. "Cabozantinib for Renal Cell Carcinoma: Current and Future Paradigms." Current treatment options in oncology 18.3 (2017): 18.


Abdelaziz, Ahmed, and Ulka Vaishampayan. “Cabozantinib for the treatment of kidney cancer.” Expert Rev Anticancer Therapy. 2017 Jun 21.

Holdhoff, M., Ambady, P., Abdelaziz, A., Sarai, G., Bonekamp, D., Blakeley, J., ... & Ye, X. (2014). High-dose methotrexate with or without rituximab in newly diagnosed primary CNS lymphoma. Neurology, 83(3), 235-239.

Matthias Holdhoff, Guneet Sarai, Ahmed Abdelaziz, David Bonekamp, Stuart A. Grossman, Xiaobu Ye. High-dose methotrexate with and without rituximab for the treatment of newly diagnosed primary CNS lymphoma: Johns Hopkins Hospital experience; ASCO 2013 ASCO Annual Meeting (May 31 - June 4, 2013).

Ahmed Abdelaziz, Vuk Sekicki. A case of myasthenia gravis presenting with apnea: an unusual presentation of the neuromuscular disease; ACP Maryland chapter meeting 2012.

Rihab Sharara, Safa Hegazin, Inas Abuali, Ahmed Abdelaziz, Sapna Kuehl. Norovirus deserves our respect; ACP Maryland chapter meeting 2013.

After graduating from the University of Alexandria, Dr. Abdelaziz completed his internal medicine residency in Baltimore, MD. During his residency, he participated in brain cancer research at Johns Hopkins Hospital. He finished his combined hematology and medical oncology fellowship at Karmanos Cancer Institute/Wayne State University. During his fellowship, he published in the field of kidney cancer. He has a special interest in lung cancer and breast cancer.

My ultimate goal is to help patients live longer and lead healthier lives. Quality of life is extremely important. This can be achieved by using recent advances in precision and individualized medicine as well as immunotherapy, which have changed the landscape of cancer treatment tremendously.

Beside all the new advances in diagnosis and treatment, it is very important to treat the person, not the diagnosis. Understanding the goals and values of each patient is an integral part of any treatment plan.

4worldlovers: During his career as a medical oncologist / hematologist, Dr. Modiano has developed a special interest in breast, lung, and gastrointestinal malignancies, and clinical trials.

Dr. Modiano was the Director of the Gastro-Intestinal Oncology Program, as well as the minority cancer control program at the University of Arizona.

Past Chief of the Division of Hematology and Oncology and Past President of Medical Staff at Carondelet St. Mary’s Hospital

Dr. Modiano currently serves as Medical Director of Arizona Clinical Research Center.

In 2006, Governor Napolitano appointed Dr. Modiano a commissioner to the Arizona Biomedical Research Commission. He has received numerous research and community service awards, including the Surgeon General Certificate of Merit.

Dr. Modiano has published many peer-reviewed articles. He has also been a presenter at multiple national and international meetings.